Medifast Stock Price, News & Analysis (NYSE:MED)

$66.50 -2.61 (-3.78 %)
(As of 02/21/2018 08:19 AM ET)
Previous Close$69.11
Today's Range$66.46 - $69.00
52-Week Range$40.00 - $74.78
Volume86,400 shs
Average Volume88,274 shs
Market Capitalization$824.73 million
P/E Ratio32.76
Dividend Yield2.78%
Beta0.54

About Medifast (NYSE:MED)

Medifast logoMedifast, Inc. produces, distributes and sells weight loss, weight management, and healthy living products, and other consumable health and nutritional products. The Company’s product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products, and vitamins. Its business units include Optavia, Medifast Direct, Franchise Medifast Weight Control Centers (MWCC) and Medifast Wholesale. Optavia is a personal coaching division of the Company that consists of Optavia Coaches, who provides coaching and support to clients utilizing the Optavia platform. Medifast Direct is its direct-to-consumer business unit that allows customers to order Medifast products directly through its Website or its in-house call center. The MWCC business unit sells product through franchise and reseller locations, which offers structured programs and a team of professionals to help customers achieve weight-loss and weight-management success at center locations.

Receive MED News and Ratings via Email

Sign-up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Special Foods & Welbeing Products
Sub-IndustryPersonal Products
SectorConsumer Staples
SymbolNYSE:MED
CUSIP58470H10
Phone732-764-0619

Debt

Debt-to-Equity RatioN/A
Current Ratio4.39%
Quick Ratio3.78%

Price-To-Earnings

Trailing P/E Ratio32.7587820629658
Forward P/E Ratio30.65
P/E Growth1.77

Sales & Book Value

Annual Sales$274.53 million
Price / Sales2.89
Cash Flow$2.27 per share
Price / Cash29.24
Book Value$8.10 per share
Price / Book8.21

Profitability

Trailing EPS$2.03
Net Income$17.83 million
Net Margins8.58%
Return on Equity24.07%
Return on Assets19.31%

Miscellaneous

Employees422
Outstanding Shares11,930,000

Medifast (NYSE:MED) Frequently Asked Questions

What is Medifast's stock symbol?

Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."

How often does Medifast pay dividends? What is the dividend yield for Medifast?

Medifast announced a quarterly dividend on Thursday, December 7th. Shareholders of record on Friday, December 22nd will be paid a dividend of $0.48 per share on Thursday, February 8th. This represents a $1.92 dividend on an annualized basis and a yield of 2.89%. The ex-dividend date of this dividend is Thursday, December 21st. This is a positive change from Medifast's previous quarterly dividend of $0.32. View Medifast's Dividend History.

How were Medifast's earnings last quarter?

Medifast Inc (NYSE:MED) announced its earnings results on Tuesday, November, 7th. The specialty retailer reported $0.55 EPS for the quarter, beating analysts' consensus estimates of $0.51 by $0.04. The specialty retailer earned $77.20 million during the quarter, compared to analyst estimates of $74.94 million. Medifast had a net margin of 8.58% and a return on equity of 24.07%. The firm's revenue was up 12.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.51 EPS. View Medifast's Earnings History.

When will Medifast make its next earnings announcement?

Medifast is scheduled to release their next quarterly earnings announcement on Thursday, March, 8th 2018. View Earnings Estimates for Medifast.

Where is Medifast's stock going? Where will Medifast's stock price be in 2018?

2 Wall Street analysts have issued 1 year price targets for Medifast's shares. Their forecasts range from $55.00 to $89.00. On average, they expect Medifast's stock price to reach $72.00 in the next year. View Analyst Ratings for Medifast.

Who are some of Medifast's key competitors?

Who are Medifast's key executives?

Medifast's management team includes the folowing people:

  • Daniel R. Chard, Chief Executive Officer, Director (Age 52)
  • Timothy G. Robinson CPA, Chief Financial Officer (Age 52)
  • Jason L. Groves Esq., Executive Vice President, General Counsel (Age 46)
  • Jeanne M. City, Executive Vice President - Human Resources (Age 57)
  • Joseph P. Kelleman, Vice President - Finance, Corporate Controller (Age 62)
  • Michael Charles MacDonald, Non-Executive Chairman of the Board (Age 64)
  • Jeffrey J. Brown, Lead Independent Director (Age 56)
  • Constance J. Hallquist, Director (Age 53)
  • Kevin G. Byrnes, Independent Director (Age 69)
  • Charles P. Connolly, Independent Director (Age 68)

Who owns Medifast stock?

Medifast's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (13.28%), Acadian Asset Management LLC (3.84%), American Century Companies Inc. (2.46%), Arrowstreet Capital Limited Partnership (1.59%), Geode Capital Management LLC (1.57%) and Bank of New York Mellon Corp (1.49%). Company insiders that own Medifast stock include Balanced Master Fund L Visium, Glenn W Welling, Jeffrey J Brown, Jeremy John Martin, Margaret Sheetz, Ralph Rushton and Simon TP Ridgway. View Institutional Ownership Trends for Medifast.

Who sold Medifast stock? Who is selling Medifast stock?

Medifast's stock was sold by a variety of institutional investors in the last quarter, including Kennedy Capital Management Inc., Bank of New York Mellon Corp, Spark Investment Management LLC, Chickasaw Capital Management LLC, Ingalls & Snyder LLC, Schroder Investment Management Group, Martingale Asset Management L P and American Century Companies Inc.. Company insiders that have sold Medifast company stock in the last year include Glenn W Welling, Jeremy John Martin and Ralph Rushton. View Insider Buying and Selling for Medifast.

Who bought Medifast stock? Who is buying Medifast stock?

Medifast's stock was acquired by a variety of institutional investors in the last quarter, including Old Mutual Global Investors UK Ltd., BlackRock Inc., WINTON GROUP Ltd, Arrowstreet Capital Limited Partnership, HL Financial Services LLC, Geode Capital Management LLC, Driehaus Capital Management LLC and Assenagon Asset Management S.A.. Company insiders that have bought Medifast stock in the last two years include Glenn W Welling, Jeffrey J Brown and Simon TP Ridgway. View Insider Buying and Selling for Medifast.

How do I buy Medifast stock?

Shares of Medifast can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medifast's stock price today?

One share of Medifast stock can currently be purchased for approximately $66.50.

How big of a company is Medifast?

Medifast has a market capitalization of $824.73 million and generates $274.53 million in revenue each year. The specialty retailer earns $17.83 million in net income (profit) each year or $2.03 on an earnings per share basis. Medifast employs 422 workers across the globe.

How can I contact Medifast?

Medifast's mailing address is 3600 Crondall Lane, OWINGS MILLS MD, 21117. The specialty retailer can be reached via phone at 732-764-0619 or via email at [email protected]


MarketBeat Community Rating for Medifast (MED)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  157 (Vote Outperform)
Underperform Votes:  182 (Vote Underperform)
Total Votes:  339
MarketBeat's community ratings are surveys of what our community members think about Medifast and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Medifast (NYSE:MED) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.502.502.502.50
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $72.00$72.00$64.50N/A
Price Target Upside: 0.84% upside0.84% upside12.13% upsideN/A

Medifast (NYSE:MED) Consensus Price Target History

Price Target History for Medifast (NYSE:MED)

Medifast (NYSE:MED) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/8/2017DA DavidsonBoost Price TargetBuy$89.00MediumView Rating Details
9/21/2017SidotiReiterated RatingNeutral$49.00 -> $55.00LowView Rating Details
8/4/2016WunderlichBoost Price TargetHold$32.00 -> $36.00N/AView Rating Details
(Data available from 2/21/2016 forward)

Earnings

Medifast (NYSE:MED) Earnings History and Estimates Chart

Earnings by Quarter for Medifast (NYSE:MED)

Medifast (NYSE MED) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/21/2018$0.48N/AView Earnings Details
11/7/2017Q3 2017$0.51$0.55$74.94 million$77.20 millionViewN/AView Earnings Details
8/8/2017Q2 2017$0.53$0.63$71.96 million$75.70 millionViewListenView Earnings Details
5/4/2017Q1 2017$0.49$0.51$72.36 million$70.62 millionViewListenView Earnings Details
3/9/2017Q4 2016$0.33$0.34$65.01 million$62.50 millionViewListenView Earnings Details
11/3/2016Q316$0.45$0.51$66.79 million$68.57 millionViewN/AView Earnings Details
8/3/2016Q216$0.51$0.63$72.01 million$71.14 millionViewN/AView Earnings Details
5/4/2016Q116$0.33$0.42$69.31 million$72.30 millionViewN/AView Earnings Details
3/10/2016Q415$0.35$0.33$62.98 million$61.30 millionViewListenView Earnings Details
11/5/2015Q315$0.42$0.45$67.00 million$65.90 millionViewN/AView Earnings Details
8/5/2015Q215$0.48$0.48$72.79 million$72.20 millionViewN/AView Earnings Details
5/7/2015Q115$0.35$0.46$71.80 million$73.30 millionViewN/AView Earnings Details
3/12/2015Q414$0.46$0.38$69.40 million$62.30 millionViewN/AView Earnings Details
11/5/2014Q314$0.36$0.47$76.10 million$74.00 millionViewN/AView Earnings Details
8/7/2014Q114$0.40$0.44$87.30 million$80.88 millionViewN/AView Earnings Details
5/5/2014Q1$0.37$0.45$87.60 million$86.50 millionViewN/AView Earnings Details
3/10/2014Q413$0.36$0.39$80.83 million$77.30 millionViewN/AView Earnings Details
11/5/2013Q313$0.42$0.41$95.07 million$86.48 millionViewN/AView Earnings Details
8/6/2013Q2 2013$0.51$0.51$101.30 million$97.10 millionViewN/AView Earnings Details
5/8/2013Q1 2013$0.34$0.43$93.77 million$96.00 millionViewN/AView Earnings Details
3/7/2013Q4 2012$0.25$0.28$82.90 million$83.20 millionViewN/AView Earnings Details
11/5/2012Q312$0.40$0.42$89.73 million$91.00 millionViewN/AView Earnings Details
7/26/2012$0.38$0.47ViewN/AView Earnings Details
5/8/2012$0.38$0.29ViewN/AView Earnings Details
3/13/2012$0.21$0.08ViewN/AView Earnings Details
11/3/2011$0.38$0.36ViewN/AView Earnings Details
8/4/2011$0.47$0.41ViewN/AView Earnings Details
5/9/2011$0.41$0.44ViewN/AView Earnings Details
3/31/2011$0.32$0.23ViewN/AView Earnings Details
11/4/2010Q3 2010$0.39$0.39ViewN/AView Earnings Details
8/5/2010Q2 2010$0.34$0.38ViewN/AView Earnings Details
5/5/2010Q1 2010$0.27$0.33ViewN/AView Earnings Details
3/4/2010Q4 2009$0.19$0.21ViewN/AView Earnings Details
10/29/2009Q3 2009$0.19$0.23ViewN/AView Earnings Details
7/30/2009Q2 2009$0.18$0.20ViewN/AView Earnings Details
4/29/2009Q1 2009$0.12$0.17ViewN/AView Earnings Details
3/12/2009Q4 2008$0.07ViewN/AView Earnings Details
11/6/2008Q3 2008$0.11$0.11ViewN/AView Earnings Details
8/7/2008Q2 2008$0.09$0.11ViewN/AView Earnings Details
5/12/2008Q1 2008$0.11$0.10ViewN/AView Earnings Details
3/12/2008Q4 2007$0.06$0.04ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Medifast (NYSE:MED) Earnings Estimates

2018 EPS Consensus Estimate: $2.57
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.61$0.61$0.61
Q2 20181$0.73$0.73$0.73
Q3 20181$0.67$0.67$0.67
Q4 20181$0.56$0.56$0.56
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Medifast (NYSE:MED) Dividend Information

Most Recent Dividend:2/8/2018
Annual Dividend:$1.92
Dividend Yield:2.89%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:94.58% (Trailing 12 Months of Earnings)
88.48% (Based on This Year's Estimates)
73.85% (Based on Next Year's Estimates)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Medifast (NYSE:MED)

Medifast (NYSE:MED) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
12/7/2017quarterly$0.482.69%12/21/201712/22/20172/8/2018
9/7/2017quarterly$0.322.31%9/21/20179/22/201711/9/2017
6/7/2017Quarterly$0.323.1%6/21/20176/23/20178/9/2017
3/8/2017quarterly$0.322.92%3/21/20173/23/20175/9/2017
12/9/2016quarterly$0.323.13%12/21/201612/23/20162/9/2017
9/9/2016quarterly$0.252.75%9/21/20169/23/201611/10/2016
6/16/2016quarterly$0.253.04%6/23/20166/27/20168/10/2016
3/10/2016quarterly$0.253.25%3/17/20163/21/20165/10/2016
12/16/2015special$0.2512/23/201512/28/20152/10/2016
(Data available from 1/1/2013 forward)

Insider Trades

Medifast (NYSE MED) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 5.40%
Institutional Ownership Percentage: 91.75%
Insider Trades by Quarter for Medifast (NYSE:MED)
Institutional Ownership by Quarter for Medifast (NYSE:MED)

Medifast (NYSE MED) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/1/2017Glenn W WellingDirectorSell275,000$64.60$17,765,000.00View SEC Filing  
11/13/2017Glenn W WellingDirectorSell250,000$65.00$16,250,000.00View SEC Filing  
9/21/2017Ralph RushtonDirectorSell25,000$0.18$4,500.00
9/6/2017Jeremy John MartinDirectorSell131,500$0.18$23,670.00
7/7/2017Simon T.P. RidgwayInsiderBuy1,500$0.15$225.00
7/5/2017Simon T.P. RidgwayInsiderBuy29,000$0.15$4,350.00
3/14/2017Glenn W WellingDirectorBuy17,084$41.33$706,081.725,309View SEC Filing  
11/15/2016Glenn W WellingDirectorBuy35,000$39.02$1,365,700.002,670View SEC Filing  
11/9/2016Jeffrey J BrownDirectorBuy10,000$38.71$387,100.0013,254View SEC Filing  
5/31/2016Balanced Master Fund L VisiumMajor ShareholderSell1,350,000$30.25$40,837,500.001,247,882View SEC Filing  
4/1/2016Margaret SheetzCOOSell8,333$30.02$250,156.66327,346View SEC Filing  
2/1/2016Margaret SheetzCOOSell8,333$28.62$238,490.46336,762View SEC Filing  
12/1/2015Margaret SheetzCOOSell8,333$29.92$249,323.36353,428View SEC Filing  
11/2/2015Margaret SheetzCOOSell8,333$28.72$239,323.76361,761View SEC Filing  
10/5/2015Margaret SheetzCOOSell8,333$28.88$240,657.04370,094View SEC Filing  
9/4/2015Simon T.P. RidgwayDirectorBuy4,000$0.08$320.00
9/3/2015Margaret SheetzCOOSell6,864$28.00$192,192.00378,427View SEC Filing  
9/2/2015Margaret SheetzCOOSell1,469$28.00$41,132.00385,291View SEC Filing  
9/1/2015Simon T.P. RidgwayDirectorBuy16,000$0.08$1,280.00
8/25/2015Simon T.P. RidgwayDirectorBuy1,000$0.09$85.00
8/24/2015Simon T.P. RidgwayDirectorBuy2,000$0.09$180.00
8/19/2015Simon T.P. RidgwayDirectorBuy15,000$0.10$1,425.00
8/18/2015Simon T.P. RidgwayDirectorBuy35,000$0.10$3,325.00
8/17/2015Radius Gold Inc.InsiderBuy5,000$0.09$450.00
8/14/2015Radius Gold Inc.InsiderBuy35,000$0.10$3,500.00
8/14/2015Simon T.P. RidgwayDirectorBuy10,000$0.10$950.00
6/25/2015Moduslink Global Solutions IncMajor ShareholderSell29,654$33.03$979,471.62View SEC Filing  
6/23/2015Moduslink Global Solutions IncMajor ShareholderSell27,443$33.01$905,893.43View SEC Filing  
6/22/2015Moduslink Global Solutions IncMajor ShareholderSell9,494$33.01$313,396.94View SEC Filing  
6/11/2015Barry B BondroffDirectorSell1,666$31.88$53,112.08View SEC Filing  
6/10/2015Margaret SheetzCOOSell8,337$32.00$266,784.00View SEC Filing  
6/4/2015John P McdanielDirectorSell3,000$32.14$96,420.00View SEC Filing  
8/18/2014Jeannette M MillsEVPSell3,000$28.03$84,090.00View SEC Filing  
6/10/2014Jason L GrovesEVPSell3,250$31.75$103,187.50View SEC Filing  
6/10/2014John P McdanielDirectorSell3,500$31.74$111,090.00View SEC Filing  
6/9/2014Jeannette M MillsEVPSell2,784$32.09$89,338.56View SEC Filing  
6/5/2014Charles P ConnollyDirectorSell7,500$30.91$231,825.00View SEC Filing  
12/2/2013Margaret Macdonald SheetzCOOSell18,000$25.63$461,340.00351,292View SEC Filing  
11/22/2013Margaret Macdonald SheetzCOOSell35,000$24.33$851,550.00369,292View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Medifast (NYSE MED) News Headlines

Source:
DateHeadline
Medifast, Inc. to Announce Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2017Medifast, Inc. to Announce Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2017
finance.yahoo.com - February 20 at 9:09 AM
Medifast (MED) versus Simply Good Foods (SMPL) Financial SurveyMedifast (MED) versus Simply Good Foods (SMPL) Financial Survey
www.americanbankingnews.com - February 17 at 11:56 AM
Contrasting Medifast (MED) & Simply Good Foods (SMPL)Contrasting Medifast (MED) & Simply Good Foods (SMPL)
www.americanbankingnews.com - February 15 at 9:12 PM
Medifast (MED) to Release Earnings on WednesdayMedifast (MED) to Release Earnings on Wednesday
www.americanbankingnews.com - February 14 at 2:56 AM
Analyzing Medifast (MED) and Simply Good Foods (SMPL)Analyzing Medifast (MED) and Simply Good Foods (SMPL)
www.americanbankingnews.com - February 11 at 1:12 AM
Head-To-Head Analysis: Simply Good Foods (SMPL) and Medifast (MED)Head-To-Head Analysis: Simply Good Foods (SMPL) and Medifast (MED)
www.americanbankingnews.com - February 7 at 5:32 AM
Head-To-Head Review: Simply Good Foods (SMPL) versus Medifast (MED)Head-To-Head Review: Simply Good Foods (SMPL) versus Medifast (MED)
www.americanbankingnews.com - February 4 at 3:04 PM
Critical Contrast: Medifast (MED) versus Simply Good Foods (SMPL)Critical Contrast: Medifast (MED) versus Simply Good Foods (SMPL)
www.americanbankingnews.com - February 4 at 1:22 PM
Analyzing Medifast (MED) & Simply Good Foods (SMPL)Analyzing Medifast (MED) & Simply Good Foods (SMPL)
www.americanbankingnews.com - January 30 at 7:12 PM
Simply Good Foods (SMPL) versus Medifast (MED) Critical ReviewSimply Good Foods (SMPL) versus Medifast (MED) Critical Review
www.americanbankingnews.com - January 30 at 11:06 AM
Contrasting Simply Good Foods (SMPL) & Medifast (MED)Contrasting Simply Good Foods (SMPL) & Medifast (MED)
www.americanbankingnews.com - January 29 at 5:14 PM
Medifast (MED) and Simply Good Foods (SMPL) Financial ReviewMedifast (MED) and Simply Good Foods (SMPL) Financial Review
www.americanbankingnews.com - January 26 at 5:06 AM
Scott Burger, the man who helped bring Pandora HQ to city, leaving companyScott Burger, the man who helped bring Pandora HQ to city, leaving company
www.bizjournals.com - January 18 at 9:44 AM
OPTAVIA® Featured in PEOPLEs Annual Half Their Size IssueOPTAVIA® Featured in PEOPLE's Annual Half Their Size Issue
finance.yahoo.com - January 16 at 9:28 AM
Medifast (MED) Upgraded at Zacks Investment ResearchMedifast (MED) Upgraded at Zacks Investment Research
www.americanbankingnews.com - January 13 at 10:54 AM
Medifast (MED) Upgraded to "Buy" at Zacks Investment ResearchMedifast (MED) Upgraded to "Buy" at Zacks Investment Research
www.americanbankingnews.com - January 6 at 12:20 AM
Top Ranked Income Stocks to Buy for December 26thTop Ranked Income Stocks to Buy for December 26th
finance.yahoo.com - December 26 at 2:42 PM
Heres Why You Should Buy Medifast (MED) Stock Right NowHere's Why You Should Buy Medifast (MED) Stock Right Now
www.zacks.com - December 23 at 5:14 AM
Medifast, Inc. : MED-US: Dividend Analysis : December 22nd, 2017 (record date) : By the numbers : December 22, 2017Medifast, Inc. : MED-US: Dividend Analysis : December 22nd, 2017 (record date) : By the numbers : December 22, 2017
finance.yahoo.com - December 23 at 5:14 AM
Here's Why You Should Buy Medifast (MED) Stock Right NowHere's Why You Should Buy Medifast (MED) Stock Right Now
finance.yahoo.com - December 22 at 9:32 AM
Medifast, Inc. to Participate in the 20th Annual ICR ConferenceMedifast, Inc. to Participate in the 20th Annual ICR Conference
finance.yahoo.com - December 21 at 9:23 AM
General Mills (GIS) Q2 Earnings Meet, Ups Organic Sales ViewGeneral Mills (GIS) Q2 Earnings Meet, Ups Organic Sales View
finance.yahoo.com - December 20 at 5:22 PM
EX-Dividend Schedule: Medifast Raised its Dividend by 50%; Will Trade Ex-Dividend on December 21, 2017EX-Dividend Schedule: Medifast Raised its Dividend by 50%; Will Trade Ex-Dividend on December 21, 2017
finance.yahoo.com - December 20 at 9:25 AM
Read This Before Buying Medifast Inc (NYSE:MED) For Its Upcoming $0.48 DividendRead This Before Buying Medifast Inc (NYSE:MED) For Its Upcoming $0.48 Dividend
finance.yahoo.com - December 17 at 5:28 PM
DA Davidson Comments on Medifast Incs Q1 2018 Earnings (MED)DA Davidson Comments on Medifast Inc's Q1 2018 Earnings (MED)
www.americanbankingnews.com - December 11 at 3:38 AM
Medifast (MED) Given New $89.00 Price Target at DA DavidsonMedifast (MED) Given New $89.00 Price Target at DA Davidson
www.americanbankingnews.com - December 8 at 9:02 PM
Medifast Inc (MED) Plans Dividend Increase - $0.48 Per ShareMedifast Inc (MED) Plans Dividend Increase - $0.48 Per Share
www.americanbankingnews.com - December 7 at 5:34 PM
Medifast, Inc. Announces 50 Percent Increase in Quarterly DividendMedifast, Inc. Announces 50 Percent Increase in Quarterly Dividend
finance.yahoo.com - December 6 at 5:27 PM
Medifast Inc (MED) Director Sells $17,765,000.00 in StockMedifast Inc (MED) Director Sells $17,765,000.00 in Stock
www.americanbankingnews.com - December 5 at 5:34 PM
ValuEngine Downgrades Medifast (MED) to HoldValuEngine Downgrades Medifast (MED) to Hold
www.americanbankingnews.com - December 3 at 8:14 AM
MED Dividend Yield Pushes Above 2%MED Dividend Yield Pushes Above 2%
www.thestreet.com - November 17 at 3:57 PM
Medifast Inc (MED) Director Sells $16,250,000.00 in StockMedifast Inc (MED) Director Sells $16,250,000.00 in Stock
www.americanbankingnews.com - November 15 at 7:30 PM
FY2017 EPS Estimates for Medifast Inc (MED) Lifted by DA DavidsonFY2017 EPS Estimates for Medifast Inc (MED) Lifted by DA Davidson
www.americanbankingnews.com - November 9 at 7:34 AM
Noteworthy Wednesday Option Activity: IMPV, MED, CSODNoteworthy Wednesday Option Activity: IMPV, MED, CSOD
www.thestreet.com - November 8 at 5:51 PM
Medifast profit beats estimates as sales rise almost 13 percentMedifast profit beats estimates as sales rise almost 13 percent
www.bizjournals.com - November 8 at 5:51 PM
Edited Transcript of MED earnings conference call or presentation 7-Nov-17 9:30pm GMTEdited Transcript of MED earnings conference call or presentation 7-Nov-17 9:30pm GMT
finance.yahoo.com - November 8 at 5:50 PM
Mid-Day Market Update: CECO Environmental Drops After Q3 Results; Forterra Shares SurgeMid-Day Market Update: CECO Environmental Drops After Q3 Results; Forterra Shares Surge
feeds.benzinga.com - November 8 at 12:44 PM
Medifast Inc (MED) Issues Q4 Earnings GuidanceMedifast Inc (MED) Issues Q4 Earnings Guidance
www.americanbankingnews.com - November 7 at 6:35 PM
MEDIFAST INC (MED) Announces Quarterly  Earnings ResultsMEDIFAST INC (MED) Announces Quarterly Earnings Results
www.americanbankingnews.com - November 7 at 5:27 PM
Medifast Inc (MED) Set to Announce Earnings on TuesdayMedifast Inc (MED) Set to Announce Earnings on Tuesday
www.americanbankingnews.com - October 31 at 1:16 PM
ETFs with exposure to Medifast, Inc. : October 30, 2017ETFs with exposure to Medifast, Inc. : October 30, 2017
finance.yahoo.com - October 31 at 5:16 AM
Medifast, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2017Medifast, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2017
finance.yahoo.com - October 19 at 6:13 AM
Medifast, Inc. : MED-US: Dividend Analysis : September 22nd, 2017 (record date) : By the numbers : October 10, 2017Medifast, Inc. : MED-US: Dividend Analysis : September 22nd, 2017 (record date) : By the numbers : October 10, 2017
finance.yahoo.com - October 11 at 8:26 PM
Medifast, Inc. : MED-US: Dividend Analysis : September 22nd, 2017 (record date) : By the numbers : October 10, 2017Medifast, Inc. : MED-US: Dividend Analysis : September 22nd, 2017 (record date) : By the numbers : October 10, 2017
finance.yahoo.com - October 10 at 8:11 PM
ETFs with exposure to Medifast, Inc. : October 9, 2017ETFs with exposure to Medifast, Inc. : October 9, 2017
finance.yahoo.com - October 9 at 4:03 PM
Medifast®, Together With its Community of OPTAVIA Coaches™, Donate More Than $60,000 to Hurricane Harvey Relief EffortsMedifast®, Together With its Community of OPTAVIA Coaches™, Donate More Than $60,000 to Hurricane Harvey Relief Efforts
finance.yahoo.com - September 26 at 9:13 AM
Sidoti Reiterates Neutral Rating for Medifast Inc (MED)Sidoti Reiterates Neutral Rating for Medifast Inc (MED)
www.americanbankingnews.com - September 21 at 6:58 PM
ETFs with exposure to Medifast, Inc. : September 19, 2017ETFs with exposure to Medifast, Inc. : September 19, 2017
finance.yahoo.com - September 20 at 6:16 AM
Medifast® Announces New Corporate Headquarters in Baltimore CityMedifast® Announces New Corporate Headquarters in Baltimore City
finance.yahoo.com - September 18 at 9:16 PM
Medifast confirms headquarters move to Harbor EastMedifast confirms headquarters move to Harbor East
finance.yahoo.com - September 18 at 9:16 PM

SEC Filings

Medifast (NYSE:MED) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Medifast (NYSE:MED) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Medifast (NYSE MED) Stock Chart for Wednesday, February, 21, 2018

Loading chart…

This page was last updated on 2/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.